• Interaction Score: 1.84

    Interaction Types & Directionality:
    inverse agonist (inhibitory)
    antagonist (inhibitory)

    Interaction Info:
    Novel drug target Established target
    Trial Name Pimavanserin

    PMIDs:
    24016069


    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiparkinson agent
    Drug Class small molecule
    FDA Approval not approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D0J8JP TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: